CAM
MDT icon

Chesapeake Asset Management’s Medtronic MDT Stock Holding History

Chesapeake Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$9.52K – 383
2025
Q3 		$9.52K Hold
100
– – 0.01% 232
2025
Q2 		$8.72K Sell
100
-5
-5% -$424 0.01% 224
2025
Q1 		$9.44K Buy
105
+5
+5% +$447 0.01% 220
2024
Q4 		$7.99K Sell
100
-200
-67% -$17.3K 0.01% 226
2024
Q3 		$27K Sell
300
-10
-3% -$841 0.02% 155
2024
Q2 		$24.4K Sell
310
-50
-14% -$4.1K 0.02% 155
2024
Q1 		$31.4K Sell
360
-2,761
-88% -$236K 0.03% 138
2023
Q4 		$257K Sell
3,121
-5,089
-62% -$388K 0.23% 74
2023
Q3 		$643K Buy
8,210
+2,494
+44% +$209K 0.62% 47
2023
Q2 		$504K Sell
5,716
-1,000
-15% -$86.1K 0.45% 56
2023
Q1 		$541K Buy
+6,716
New +$547K 0.5% 55

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chesapeake Asset Management's MDT Position: Q4 2025 in Review

Chesapeake Asset Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 100 shares — an estimated $9.52K sold.

Chesapeake Asset Management first reported a position in MDT in Q1 2023 and held it in 11 quarters. The position peaked at $643K in Q3 2023. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Chesapeake Asset Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 100 Medtronic shares in Q4 2025, an estimated $9.52K.
  • Chesapeake Asset Management first reported a position in Medtronic in Q1 2023 and held it in 11 quarters.
  • Chesapeake Asset Management's Medtronic position peaked at $643K in Q3 2023.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Chesapeake Asset Management's 13F filing for Q4 2025, filed 8 Jan 2026.